Over the past weekend, Ripal Gandhi, M.D., FSVM, FSIR presented, “Advances in Pancreatic Cancer: Trans-arterial Therapy on the Horizon,” at the Symposium on Clinical Interventional Oncology (CIO). Dr. Gandhi highlighted RenovoRx's proprietary Trans-Arterial Micro-Perfusion (TAMP™) therapy platform designed to ensure precise delivery for targeted treatment of cancer, and its potential for increased safety, tolerance, and improved efficacy. View the presentation here: https://bit.ly/3LDnQz8 #CIO2023 #PancreaticCancer #LocallyAdvancedPancreaticCancer #LAPC
Over the past weekend, Ripal Gandhi, M.D., FSVM, FSIR presented, “Advances in Pancreatic Cancer: Trans-arterial Therapy on the Horizon,” at the Symposium on Clinical Interventional Oncology (CIO). Dr. Gandhi highlighted RenovoRx's proprietary Trans-Arterial Micro-Perfusion (TAMP™) therapy platform designed to ensure precise delivery for targeted treatment of cancer, and its potential for increased safety, tolerance, and improved efficacy. View the presentation here: https://bit.ly/3LDnQz8 #CIO2023 #PancreaticCancer #LocallyAdvancedPancreaticCancer #LAPC
